These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38311425)

  • 21. Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.
    Delamarre A; Tison F; Li Q; Galitzky M; Rascol O; Bezard E; Meissner WG
    J Neural Transm (Vienna); 2019 Jun; 126(6):789-793. PubMed ID: 31098725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.
    Kim JM; Lee KH; Choi YL; Choe GY; Jeon BS
    Mov Disord; 2002 Sep; 17(5):1089-90. PubMed ID: 12360566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
    Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
    Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noradrenergic drugs for levodopa-induced dyskinesia.
    Colosimo C; Craus A
    Clin Neuropharmacol; 2003; 26(6):299-305. PubMed ID: 14646609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?
    Chung SJ; Yoo HS; Lee HS; Jeong HE; Kim SJ; Oh JS; Kim JS; Sohn YH; Lee PH
    CNS Drugs; 2018 Oct; 32(10):971-979. PubMed ID: 30027399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study.
    Nimura T; Ando T; Yamaguchi K; Nakajima T; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2004 Apr; 100(4):606-10. PubMed ID: 15070112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease.
    Watts RL; Lyons KE; Pahwa R; Sethi K; Stern M; Hauser RA; Olanow W; Gray AM; Adams B; Earl NL;
    Mov Disord; 2010 May; 25(7):858-66. PubMed ID: 20461803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia.
    Molchadski I; Korczyn AD; Cohen OS; Katzav A; Nitzan Z; Chapman J; Hassin-Baer S
    Acta Neurol Scand; 2011 Feb; 123(2):117-21. PubMed ID: 21108621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amantadine treatment and delayed onset of levodopa-induced dyskinesia in patients with early Parkinson's disease.
    Wang CC; Wu TL; Lin FJ; Tai CH; Lin CH; Wu RM
    Eur J Neurol; 2022 Apr; 29(4):1044-1055. PubMed ID: 34962701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of Tianqi Pingchan Granule, a compound Chinese herbal medicine, for levodopa-induced dyskinesia in Parkinson's disease: A randomized double-blind placebo-controlled trial.
    Zhang Y; Zhu XB; Zhao Y; Cui GY; Li WT; Yuan CX; Huang JP; Wan Y; Wu N; Song L; Zhao JH; Liang Y; Xu CY; Liu MJ; Gao C; Chen XX; Liu ZG
    J Integr Med; 2024 Sep; 22(5):545-551. PubMed ID: 39060125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson's disease patients.
    Dias CMV; Leal DAB; Brys I
    Int J Neurosci; 2023 Dec; 133(12):1319-1325. PubMed ID: 35603453
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dyskinesia in Parkinson's disease: an update on new neuroimaging methods and treatment possibilities].
    Thomsen BL; Herz DM; Siebner HR; Løkkegaard A
    Ugeskr Laeger; 2017 Mar; 179(10):. PubMed ID: 28263159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia.
    Fan SY; Wang KL; Hu W; Eisinger RS; Han A; Han CL; Wang Q; Michitomo S; Zhang JG; Wang F; Ramirez-Zamora A; Meng FG
    Ann Clin Transl Neurol; 2020 Jan; 7(1):59-68. PubMed ID: 31813194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).
    Oertel W; Eggert K; Pahwa R; Tanner CM; Hauser RA; Trenkwalder C; Ehret R; Azulay JP; Isaacson S; Felt L; Stempien MJ
    Mov Disord; 2017 Dec; 32(12):1701-1709. PubMed ID: 28833562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amantadine Extended-Release (GOCOVRI
    Paik J; Keam SJ
    CNS Drugs; 2018 Aug; 32(8):797-806. PubMed ID: 30088203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levodopa-induced dyskinesia in Parkinson's disease: still no proof? A meta-analysis.
    Giannakis A; Chondrogiorgi M; Tsironis C; Tatsioni A; Konitsiotis S
    J Neural Transm (Vienna); 2018 Sep; 125(9):1341-1349. PubMed ID: 29352351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.
    Horstink MW; Zijlmans JC; Pasman JW; Berger HJ; van't Hof MA
    J Neurol Neurosurg Psychiatry; 1990 Mar; 53(3):224-6. PubMed ID: 2324754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease.
    Fox SH; Metman LV; Nutt JG; Brodsky M; Factor SA; Lang AE; Pope LE; Knowles N; Siffert J
    Mov Disord; 2017 Jun; 32(6):893-903. PubMed ID: 28370447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.
    Vasta R; Nicoletti A; Mostile G; Dibilio V; Sciacca G; Contrafatto D; Cicero CE; Raciti L; Luca A; Zappia M
    PLoS One; 2017; 12(2):e0172145. PubMed ID: 28207803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology.
    Mera TO; Burack MA; Giuffrida JP
    Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():154-7. PubMed ID: 23365855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.